ASX 200 (XJO) down 2.2%, tech shares decline

The ASX 200 (ASX: XJO) is currently down 2.2% as selling intensified in the US share market.

Tech tech declines

The NASDAQ 100 (NDX) fell overnight. The Afterpay Ltd (ASX: APT) share price is down 5.2%.

There has been broad declines as investors push the sell button. Keep in mind that some ASX shares are only dropping back to prices where they were at a few weeks ago. But it is noticeable that volatility is increasing.

The ASX 200 has a number of technology businesses that have dropped:

The Megaport Ltd (ASX: MP1) share price is down 6%.

The WiseTech Global Ltd (ASX: WTC) share price is down 2%.

The Appen Ltd (ASX: APX) share price is down 3%.

Soon-to-be ASX 200 business Zip Co Ltd (ASX: Z1P) has seen its share price drop 4%.

Vaccine delay?

Other news may also be disturbing investors today. A COVID-19 vaccine is a key hope for the world returning to normal.

However, media is reporting that clinical trials for a vaccine being developed by AstraZeneca and Oxford University has been put on hold after a participant has reportedly had an adverse reaction in the UK.

The UK vaccine is currently in phase 3 of testing after successful phase 1 and phase 2 testing. There are 30,000 participants across the world. But this is actually the second time the vaccine trial has been put on hold and this happens any time a volunteer goes to hospital when the reason is uncertain. The participant is expected to recover.

Codan Limited’s (ASX:CDA) win

Codan Communications, which designs and manufactures mission-critical communications for global military and public safety applications, has won a contract with a large African government to supply tactical communications equipment.

The contract has a value order of US$10 million for the supply of Sentry-H radios and accessories.

It’s expected that the order will be delivered in the second half of FY21. The customer intends to deploy Sentry-H radios for national security purposes in military operations in a country-wide program.

The contract is a one-off purchase and there are no material conditions to be satisfied before delivery. Codan reassured investors by saying that the customer has an investment-grade credit rating with a stable outlook. It has a policy of mitigating risk with either a ‘letter of credit’ or appropriate credit insurance.

Codan said it is a significant contract as it reinforces its strength and position in the African market and enhances the strategy of trying to penetrate the global security and military sector.

Other news

The team over at Rask Media have covered the rest of today’s news, so make sure you head over there for more ASX share market coverage.

Featured Australian shares ETFs:

[ls_content_block id=”695″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report — or get it emailed to you — for FREE by CLICKING HERE NOW or the button below.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.